ENTX Latest Headlines

Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)

at www.tipranks.com (Mon, 31-Aug 9:30 AM)

Entera Bio’s $275 Million Oversubscribed Private Placement Extends Cash Runway to 2030, Funding Key Osteoporosis Trials

Market Chameleon (Mon, 27-Jul 9:52 AM)

ENTX Secures $275 Million Oversubscribed Private Placement to Fully Fund Phase 3 Trials Through 2030

Market Chameleon (Mon, 27-Jul 9:19 AM)

FDA Feedback Clears Path for Entera Bio’s Pioneering Oral Osteoporosis Treatment—Phase 3 for EB613 Set to Begin Late 2026

Market Chameleon (Tue, 23-Jun 11:44 AM)

FDA Greenlights Entera Bio’s Phase 3 Oral Osteoporosis Trial—A Potential Turning Point for Postmenopausal Women

Market Chameleon (Mon, 22-Jun 11:45 AM)